Publication:
Bivalent angiotensin II suppresses oxidative stress-induced hyper-responsiveness of angiotensin II receptor type i

dc.contributor.authorTitiwat Sungkawornen_US
dc.contributor.authorChutima Jiarpinitnunen_US
dc.contributor.authorPongkorn Chaiyakunvaten_US
dc.contributor.authorVaranuj Chatsudthipongen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T04:48:36Z
dc.date.available2018-10-19T04:48:36Z
dc.date.issued2013-04-15en_US
dc.description.abstractAngiotensin II receptor type I (AT1R) is a G-protein coupled receptor involved in regulation of body water-electrolyte balance and blood pressure. Oxidative stress promotes AT1R oligomerization and hyper-responsiveness to its cognate ligand Ang II. In this study, bivalent Ang II, synthesized by linking with aminocaproic acid (Acp) at the N-terminus, was used to induce AT1R dimerization and hyper-responsiveness in AT1R-expressed human embryonic kidney (AT1R-HEK) cells, determined using image correlation spectroscopy (ICS) and by measuring AT1R-mediated change in intracellular Ca2+concentration, respectively. In addition, ICS was employed to determine distribution pattern of cell-surface AT1R and its degree of aggregation when stimulated by monomeric (monovalent) and bivalent Ang II under oxidative stress (100 μM H2O2) condition in comparison with normal (unoxidized) AT1R-HEK cells. Bivalent Ang II induced cell-surface AT1R aggregation/clustering but maintained AT1R normal signaling response under oxidative stress condition, whereas stimulation by monomeric Ang II or a mixture of monomeric and Acp-modified Ang II (used in the synthesis of bivalent form) resulted in AT1R hyper-responsiveness. These results suggest that bivalent ligand (viz. Ang II) provides another strategy in the development of novel drugs specifically designed for attenuating aberrant responsiveness of cognate receptor (AT1R) under pathological (oxidative stress) conditions. © 2013 Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.citationEuropean Journal of Medicinal Chemistry. Vol.63, (2013), 629-634en_US
dc.identifier.doi10.1016/j.ejmech.2013.02.041en_US
dc.identifier.issn17683254en_US
dc.identifier.issn02235234en_US
dc.identifier.other2-s2.0-84875965352en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/31540
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875965352&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleBivalent angiotensin II suppresses oxidative stress-induced hyper-responsiveness of angiotensin II receptor type ien_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875965352&origin=inwarden_US

Files

Collections